In: Cardiovascular Revascularization Medicine, 2019, vol. 20, no. 7, p. 577–582
Background: The advent of bioresorbable vascular scaffolds (BVS) was considered as a potential improvement in percutaneous coronary intervention (PCI) after the groundbreaking development of drug eluting stents (DES). However, the clinical performance, long-term safety and efficacy of BVS in complex coronary lesions remain uncertain. COMPARE ABSORB, a multicenter, single blind, prospective ...
|
In: European Heart Journal, 2008, vol. 29, no. 4, p. 531-556
|
In: European Heart Journal, 2012, vol. 33, no. 24, p. 3088-3097
|
In: European Heart Journal, 2014, vol. 35, no. 10, p. 633-638
|
In: European Heart Journal, 2015, vol. 36, no. 8, p. 501-508
|
In: European Heart Journal, 2015, vol. 36, no. 17, p. 1031-1040
|
In: European Heart Journal - Cardiovascular Imaging, 2015, vol. 16, no. 5, p. 490-499
|
In: European Heart Journal, 2011, vol. 32, no. 16, p. 1986-1993
|
In: European Heart Journal - Cardiovascular Imaging, 2015, vol. 16, no. 8, p. 853-862
|